- $106.31m
- $86.28m
- $19.61m
iCAD down as preliminary Q4 sales misses estimate; CEO steps down
Brief: ICAD Expects Total Revenue For Q4 To Be About $6.5 Mln
Brief: Icad Announces Leadership Transition
Brief: ICAD Names Executive Dana Brown As CEO, Effective Immediately
Icad Inc Expected To Post A Loss Of 14 Cents A Share: Earnings Preview
Brief: iCAD Announces CFO Transition And Hires New Senior Vice President, U.S. Commercial Sales, AI
Brief: ICAD Announces Board Of Directors Transition
U.S. STOCKS ON THE MOVE-Talkspace, Flora Growth, Grindr Inc
U.S. STOCKS ON THE MOVE-Builders FirstSource, Tenaya Therapeutics, Blue Apron
iCAD soars on AI deal with Google Health
Icad Inc Reports Results For The Quarter Ended In September: Earnings Summary
Brief: iCAD Reports Financial Results For Third Quarter Ended September 30, 2022
Icad Inc Expected To Post A Loss Of 13 Cents A Share: Earnings Preview
Brief: ICAD And Solis Mammography Ink Deal To Collaborate On Use Of Ai To Evaluate Risk Of Cardiovascular Disease
U.S. RESEARCH ROUNDUP-Isoplexis, Seer, Wesco International
Icad Inc Reports Results For The Quarter Ended In June: Earnings Summary
Brief: Icad Reports Financial Results For Second Quarter 2022
Icad Inc Expected To Post A Loss Of 11 Cents A Share: Earnings Preview
Brief: iCAD Announces CFO Transition